- November 11, 2026
- Posted by: Josh Knoll
- Category: DME Billing
A few months back, the Centers for Medicare & Medicaid Services (CMS) placed 11 DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics, and Supplies) suppliers on its preclusion list. CMS made the decision after identifying more than $3.4 billion in suspected fraudulent billing during 2025 and 2026.
As per the report released on September 8th, 2026, these suppliers never submitted any claim before 2025. Upon further investigation, it was found that the service lines were billed to registered beneficiaries.
In fact, in some cases, it was found that the billed equipment was not requested or received. As per the reports, four of the 11 suppliers had previously had their Original Medicare billing privileges revoked. Follow along to see how this case of suspected $3.4 billion fraud can change the entire DME billing ecosystem.
Finer Details About the Fraud
Even though $3.4 billion is an alarming figure, it does require some consideration. The figure here represents the amount suspected by the investigative agencies. Apart from that, CMS has reported that it stopped nearly $24 million in claims in two cases before payment.
Another supplier in Florida reportedly submitted around $18.4 million in fraudulent catheter claims in a span of two days, while a Texas supplier submitted about $5.5 million in orthotics claims. In the Texas case, the beneficiaries failed to recognize the equipment. CMS also identified about nine other beneficiaries with services dated after their deaths.
Even though these figures look alarming, these are merely administrative findings. Proof of any serious misconduct is still being investigated. But at the core of things, it raises serious questions about security.
Related Reading: Sunknowledge Serves you Proactive DME Billing Support
Why the Allegations Matter Beyond the 11 Suppliers
Regardless of the factual accuracy of the incident, this is certainly going to impact the DME billing ecosystem for the coming years. Therefore, providers need to be more careful and look at the incident in broader strokes. Here is why the allegation does not just concern the 11 suppliers put on the preclusion list, but other similar entities as well.
Consequences for DME Suppliers
As per the rules, suppliers that are put on the list will not receive payment from Medicare Advantage plans. This goes for the services as well as any items that the entity has billed. Therefore, the most immediate effect is that reimbursement will pause for these precluded entities, especially for claims that are being routed via Medicare Advantage arrangements.
Depending upon the findings, the suppliers might face issues such as payment suspension, record requests, audits, recovery of established overpayments, or an extensive review of enrollment status or payer contracts. These consequences are not standard, so not all of them will face similar consequences. But this will certainly affect a broader audience base.
In fact, legitimate billers can also face heightened scrutiny. This can seriously impede the overall pacing at which the billing operation might proceed. Historically speaking, stringent laws and regulations can slow down the billing function, which in turn impacts the billing workflow.
Consequences for Physicians and Other Providers
Treating practitioners also play a critical role in the DME ordering process. In fact, claims with high dollar value or volume might prompt additional reviews. These reviews generally target specific areas of claims, such as:
- Clinical evaluation of the patient
- Assessment of whether the equipment was medically necessary
- Authorization for the equipment
- Reviews to determine whether the equipment or the service line is supported by medical records
Given the current situation, CMS wants DME providers to review their existing order and documentation controls. Depending on the item, Medicare requirements may include a Standard Written Order, supporting medical records, a face-to-face encounter, or a written order before delivery. Just presenting an electronic signature is not enough anymore.
In fact, providers might even be asked to authenticate orders, produce encounter notes, or clarify the medical necessity for additional scrutiny. All these add workloads to the DME billing ecosystem. As a result, the overall flow of cash slows down.
Consequences for Ancillary Service Partners
This situation will not just affect the core players of the DME billing ecosystem. In fact, the ripples of this can be felt by other verticals as well. As per the regulations, billers are now expected to retain every detail like the transactional logs, call records, etc. These become useful evidence in case things go sideways.
This additional scrutiny can certainly create a regulatory minefield. Vendors with weak audit trails and workflows might face additional contract-based questions, which can result in a sizeable loss of client confidence and revenue.
Hence, it is understandable how the $3.4 billion fraud will affect others as well. It is safe to say that this starts a chain reaction which can slowly engulf the entire DME billing ecosystem.
A Practical DME Supplier Security and Compliance Matrix
Being secure requires a closed-loop system that checks details across handoffs. Here is a look at a practical security matrix that DME billing teams should adapt to keep the operation rolling.
| Control Area | Core Safeguard | Evidence To Retain |
|---|---|---|
| Identity of the supplier and enrollment | Verify details like legal entity, NPI, location of service, and payer participation. Recheck material changes and relevant exclusion or preclusion information. | Screening logs, payer contracts, accreditation, disclosures of ownership, and enrollment records |
| Beneficiary identity and coverage | Confirm the basic demographics of the beneficiary, and other details related to the service line. | Eligibility response, verification date, plan details, case notes |
| Ordering practitioner | Validate practitioner identity, NPI, and authority to order. Confirm unclear or unexpected orders through trusted practice contact details. | Signed order, practitioner details, confirmation notes |
| Coverage and medical necessity | The billing team must match the requested item to details such as the clinical record, face-to-face requirements, and the relevant prior authorization rules. | Encounter notes, medical records, applicable policy, authorization decision |
| Coding and claim construction | Coders need to ensure that the codes and modifiers are used correctly, assessing HCPCS codes, units, date of service, etc. | Coding review, claim edits, resolutions, submitted claim |
| Fulfillment and delivery | Confirm that the equipment supplied matches the order and required delivery evidence is available. Investigate partial, returned, refused, or undelivered orders. | Proof of delivery, carrier tracking, item details, exception log |
Related Reading: Practical DME Billing Documentation Checklist for Accurate Claims
How SunKnowledge Can Help Providers Reduce Exposure
The biggest DME billing challenge for providers and suppliers is to sustain these checks across every claim that a provider sends out. This opens the door for a professional DME biller like SunKnowledge.
Our billing experts take care of DME-specific billing operations like primary and secondary insurance verification, prior authorization support, physician office follow-up, order entry/confirmation, documentation collection, denial management, etc. The best part is that we offer all these services at a flat fee of just $7 per hour.
This positions SunKnowledge as not only a viable DME biller, but also one of the cheapest options available. So if you are a DME supplier who wants to stay ahead of the curve and the changing winds of DME RCM, then book a free consultation today.
FAQ
Which DMEPOS categories are most vulnerable to Medicare fraud?
As per the CMS report, components such as the urological supplies, surgical dressings, glucose monitors, and positive airway pressure devices run the highest risk of DMEPOS fraud. Out of all of these, urological claims require closer monitoring. This is because in the year 2025, CMS identified around $885 million of improper payment.
How often should DMEPOS suppliers renew their Medicare accreditation?
As per the regulations, DMEPOS suppliers should validate their Medicare enrollment close to every 12 months accordingly. This process further allows CMS to confirm that the business information of the provider is accurate.
What is the surety bond requirement for Medicare DME suppliers?
As per the requirement set by the regulatory body, the surety bond requirement is close to $50,000 for each assigned NPI. The bond is meant to work as a financial protection to Medicare against certain unpaid claims.
Can CMS review previously paid DME claims after a supplier faces a final adverse action?
As per the 42 CFR § 424.57(e)(2), CMS or any of its contractors might reopen the Medicare claims that were paid on or after the date of the supplier’s final adverse action. This is meant to assess if an overpayment was made.